When a new drug enters the market, it brings with it both hope and uncertainty. Clinical trials, despite their scientific rigor, are limited in scope — they can’t predict how a drug will behave in real-world conditions, across varied patient…
Recent Post
- Schedule H2 Expanded: Antimicrobials and Many Other Drugs Now Under Stricter Controls
- CDSCO Restricts IVF Supplies to Registered ART Centres
- CDSCO Issues Clarity on New Drugs, DC Granules & MR Pellets Licensing
- Centre Bans 16 Fixed Dose Combinations Under Section 26A of Drugs & Cosmetics Act
- India Cracks Down on Chloramphenicol & Nitrofurans in Food Producing Animals
